tiprankstipranks
Circassia Pharmaceuticals PLC (GB:NIOX)
LSE:NIOX
Holding GB:NIOX?
Track your performance easily

Circassia Pharmaceuticals (NIOX) Financial Statements

9 Followers

Circassia Pharmaceuticals Financial Overview

Circassia Pharmaceuticals's market cap is currently ―. The company's EPS TTM is p0.027; its P/E ratio is 23.45; and it has a dividend yield of 1.54%. Circassia Pharmaceuticals is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 19.40M£ 13.80M£ 12.60M£ 11.30M£ 7.40M
Total Assets£ 98.50M£ 92.20M£ 86.40M£ 89.50M£ 103.10M
Total Debt£ 1.00M£ 1.50M£ 1.30M£ 1.70M£ 1.60M
Net Debt£ -18.40M£ -12.30M£ -11.30M£ -9.60M£ -5.80M
Total Liabilities£ 16.60M£ 19.00M£ 19.60M£ 24.30M£ 37.00M
Stockholders Equity£ 81.90M£ 73.20M£ 66.80M£ 65.20M£ 66.10M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Circassia Pharmaceuticals Earnings and Revenue History

Circassia Pharmaceuticals Debt to Assets

Circassia Pharmaceuticals Cash Flow

Circassia Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis